The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olaratumab for the treatment of patients (pts) with advanced/metastatic soft tissue sarcoma (STS): Treatment patterns in the United States (US) during the first year post-approval.
 
Victor Manuel Villalobos
Consulting or Advisory Role - Abbvie; Ignyta; Janssen; Lilly; Novartis
Travel, Accommodations, Expenses - Janssen; Lilly; Xencor
 
Lisa M. Hess
Employment - Lilly
 
Yajun Zhu
Employment - Lilly
 
Tomoko Sugihara
No Relationships to Disclose
 
Pablo Lee
Employment - Lilly
 
Volker Wacheck
Employment - Lilly
 
Symantha A. Melemed
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Andrew J. Wagner
Consulting or Advisory Role - Five Prime Therapeutics; Lilly; Loxo
Research Funding - AADi (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Plexxikon (Inst)